Whilst 2020 is not the year any of us had imagined, our imaginations have not stopped. There are many possible futures that could be achieved with the right investment in life sciences, specifically the biotechnology and medical technology sectors.
But what are influential investors and industry leaders dreaming of? Where are their imaginations taking them? How can you hear about their valuable insights which could ignite your own imagination?
Optimum’s 12th annual Healthcare Investor Conference (8 October 2020), held with Dechert, now reveals three confirmed speakers:
- Linden Thomson: Fund manager at AXA Investment Managers
- Dan Mahony: Co-head of healthcare at Polar Capital
- Sean Marett: Chief Business and Chief Commercial Officer at BioNTech
Linden, Dan, and Sean, alongside a host of other experts will talk about life sciences post pandemic, including how the investment landscape looks in our Brave New World, how we’re doing in industry vs. Covid-19, what gives our speakers hope, and how we can collectively build our industry back better.
Do register here to secure your place today. Need something to ignite your imagination right now? Check out our May 2020 European Healthcare Investor Report which concluded that investors really are proactively looking for new opportunities. Something you might not have imagined during lock down.